Skip to main content
Industry News
Sanger sequencing-based COVID-19 test to be developed by BillionToOne

BillionToOne is working on its qSanger-COVID-19 test, a quantitative COVID-19 assay based on Sanger sequencing that can increase the capacity of diagnostic tests for COVID-19 by hundreds of thousands per day and get around the issue regarding reagent supplies.

Full Story: